Interaction between VEGF and one of its co-receptor neuropilin 1 (NRP1) is known to play an important role in tumor angiogenesis [27], [28] and therefore blocking their interaction could be a rational anti-angiogenic therapeutic approach for cancer treatment [28], [29]. The gene discussed is NRP1; the disease is cancer.